M&A Deal Summary

Össur hf. Acquires Gibaud SAS

On December 21, 2006, Össur hf. acquired medical products company Gibaud SAS from Azulis Capital and Equistone Partners Europe Limited for 101M EUR

Acquisition Highlights
  • This is Össur hf.’s 4th transaction in the Medical Products sector.
  • This is Össur hf.’s 1st largest (disclosed) transaction.
  • This is Össur hf.’s 1st transaction in France.

M&A Deal Summary

Date 2006-12-21
Target Gibaud SAS
Sector Medical Products
Buyer(s) Össur hf.
Sellers(s) Azulis Capital
Equistone Partners Europe Limited
Deal Type Add-on Acquisition
Deal Value 101M EUR

Target

Gibaud SAS

Saint Etienne, France
website
Gibaud SAS is a supplier of orthopaedic products including surgical corsets, elbow and knee supports in France and across Europe.

Search 167,785 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Össur hf.

Reykjavik, Iceland

website


Category Company
Founded 1971
SectorMedical Products
Employees3,500
Revenue 483M DKK (2015)
DESCRIPTION

Ossur (Icelandic Stock Exchange: OSSR) is a trusted and global leader in the development, manufacturing, distribution, sales and marketing of high technology orthotic and prosthetic devices. With its head office in Reykjavik, Iceland, the company's U.S. sales and marketing headquarters are located in Aliso Viejo, California; the Canadian office is in Vancouver, BC; the Nordic office is in Uppsala, Sweden; and the European office is in Eindhoven, Holland.


DEAL STATS #
Overall 5 of 8
Sector (Medical Products) 4 of 7
Type (Add-on Acquisition) 5 of 8
Country (France) 1 of 1
Year (2006) 2 of 2
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-18 Innovation Sports, Inc.

Foothill Ranch, California, United States

Innovation Sports, Inc. is a US-based developer, manufacturer and marketer of ligament braces, primarily for the knee, but also the wrist.

Buy $38M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-21 Teamolmed Syd AB

Jönköping, Sweden

Teamolmed Syd AB is a Swedish orthotic and prosthetic (O&P) provider. The company manufactures, adapts and provides patients with orthopedic aids. The biggest clients are a number of Swedish county councils.

Buy kr310M

Seller(S) 2

SELLER

Azulis Capital

Paris, France

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2000
PE ASSETS 1.0B EUR
SizeMiddle-Market
Type Sector Agnostic
DESCRIPTION

Azulis Capital is a private equity investment firm that targets buyout, recapitalization, and growth capital investments in France. Azulis looks to invest in mid-sized businesses with €20 to €120 million in enterprise value. Sectors of interest include consumer products and services, manufacturing, communications, healthcare, and chemicals. Azulis generally seeks to commit between €7 and €30 million per transaction. Azulis Capital was formerly known as Banexi Capital and is based in Paris.


DEAL STATS #
Overall 8 of 40
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 2 of 5
Country (France) 8 of 40
Year (2006) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-01 Vetoquinol SA

Lure, France

Vetoquinol SA is a largest veterinary pharmaceutical company. Vetoquinol was founded in 1933 and is based in Lure, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Eppe Group

Sainte Savine, France

Eppe Group is a provider of printing and publishing service.

Sell -
SELLER

Equistone Partners Europe Limited

London, United Kingdom

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 1997
PE ASSETS 6.7B EUR
SizeMega
Type Sector Agnostic
DESCRIPTION

Equistone Partners Europe Ltd is a private equity firm that invests in small to mid-sized companies with valued from €50 to €500 million. Equistone targets companies operating in the fields of services, healthcare, financial services, and consumer/travel. The Firm looks to invest €25 to €125 million in a variety of transactions, including buyouts, growth capital financings, and recapitalizations. Equistone Partners Europe Ltd. (formerly Barclays Private Equity Ltd) was formed in 1997 and is based in London.


DEAL STATS #
Overall 64 of 165
Sector (Medical Products) 2 of 5
Type (Add-on Acquisition) 26 of 53
Country (France) 21 of 51
Year (2006) 12 of 12
Size (of disclosed) 35 of 56
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-21 FEP Fahrzeugelektrik Pirna GmbH

Pirna, Germany

FEP Fahrzeugelektrik Pirna GmbH is an automotive supplier for sophisticated injection moulded plastics parts for electronic and electrical components, especially connectors and oil pressure switches.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-25 Phase Eight Ltd.

LONDON, United Kingdom

Phase Eight offers a range of evening wear, bridalwear and accessories aimed at the 35- to 55-year-old woman. It has 107 stores and 203 concessions throughout the U.K. and Ireland as well as 15 stores and 113 concessions in 16 international markets including Europe, the Middle East and Asia.

Sell £52M